Aurora Cannabis Inc. (TSE:ACB - Free Report) - Atb Cap Markets lowered their Q3 2025 EPS estimates for Aurora Cannabis in a research report issued on Monday, December 16th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.18) per share for the quarter, down from their previous forecast of ($0.13). The consensus estimate for Aurora Cannabis' current full-year earnings is ($0.22) per share. Atb Cap Markets also issued estimates for Aurora Cannabis' Q4 2025 earnings at ($0.14) EPS, FY2025 earnings at ($0.14) EPS, FY2026 earnings at ($0.23) EPS, FY2027 earnings at ($0.02) EPS and FY2029 earnings at $0.56 EPS.
Several other equities analysts also recently issued reports on ACB. ATB Capital cut their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday. TD Securities upgraded Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. Three investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of C$5.85.
Read Our Latest Research Report on ACB
Aurora Cannabis Stock Performance
Shares of TSE ACB traded down C$0.23 during midday trading on Thursday, reaching C$5.88. The company had a trading volume of 394,843 shares, compared to its average volume of 989,081. Aurora Cannabis has a 1 year low of C$3.84 and a 1 year high of C$12.85. The business's 50-day simple moving average is C$6.89 and its 200 day simple moving average is C$7.56. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The stock has a market cap of C$321.40 million, a P/E ratio of -9.33 and a beta of 2.71.
Insider Buying and Selling
In other Aurora Cannabis news, Senior Officer Andre Jerome sold 7,712 shares of the business's stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total value of C$59,382.40.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
Featured Articles
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
